Clinical Trials Browser

Phase 1 × Breast Cancer Metastatic × Docetaxel × Clear all

NCT05301530 2022-03-29

Clinical Trial to Assess Pharmacokinetic Parameters and Safety of NNG-TMAB (Trastuzumab) on Recurrent or Metastatic Breast Cancer Patients.

Phase 1 Completed

Breast Cancer Metastatic

NCT01876251 2019-03-15

A Study Evaluating The PF-03084014 In Combination With Docetaxel In Patients With Advanced Breast Cancer

Phase 1 Terminated

30 enrolled 29 charts

Breast Cancer Metastatic